Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised by CSEM and Bio-Techne, where cutting-edge innovations are taking center stage. This event is set to redefine how data-driven solutions are revolutionizing the life science sector, from bioprocesses to biopharma and health.
Continue reading
Scailyte is thrilled to attend Hanson Wade’s 14th World CB & CDx Summit – the flagship CDx event of the year in Boston, September 3-6!
Continue reading
Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD.
Continue reading
Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor. Dr. Savova brings strong expertise in computational biology, immunology, and cancer research, with a track record of high-profile publications.
Continue reading
We are thrilled to attend the Bio International Convention 2024 in San Diego on June 3-6 where business and breakthroughs converge.
Continue reading
In our latest episode of “Inside Scailyte,” we’re excited to introduce you to Dennis Göhlsdorf, our Machine Learning Engineer and co-founder at Scailyte. Dennis is at the forefront of our innovative AI-driven solutions, leveraging his expertise to drive groundbreaking advancements in single-cell omics.
Continue reading
Join us for our presentation on “Enabling Precision Medicine by Combining Single-Cell Multi-Omics Data and Artificial Intelligence” in the Single-Cell Multiomics track on Thursday, March 28 at 9:35, delivered by our Senior Data Scientist, Shaoline Sheppard.
Continue reading
In the latest episode of “Inside Scailyte,” we’re thrilled to introduce you to Shaoline Sheppard, our talented Senior Data Scientist. Shaoline plays a pivotal role in analyzing and interpreting data to drive insights and innovation at Scailyte.
Continue reading
Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our cutting-edge innovations in single-cell RNAseq data analysis, featuring a presentation on “Clinically Relevant Translation Of Single-Cell RNAseq Data Analysis Using ScaiVision” by our Senior Data Scientist, Julian Spagnuolo, on Wednesday, March 21 at 12:10.
Continue reading
In our latest white paper, “AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL”, we delve deep into the transformative impact of ScaiVision, Scailyte’s pioneering platform, on the realm of CAR-T cell therapy for Diffuse Large B-Cell Lymphoma (DLBCL).
Continue reading
